| human | Q5 |
| P496 | ORCID iD | 0000-0001-7947-3051 |
| P106 | occupation | researcher | Q1650915 |
| Q80051730 | A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings |
| Q38837639 | Accumulation of HIV-1 Drug Resistance Mutations After First-Line Immunological Failure to Evaluate the Options of Recycling NRTI Drugs in Second-Line Treatment: A Study from South India |
| Q40692790 | Anti-HIV microRNA expression in a novel Indian cohort |
| Q30432413 | Beyond surveillance: a role for respondent-driven sampling in implementation science |
| Q49837529 | Broad neutralization response in a subset of HIV-1 subtype C-infected viraemic non-progressors from southern India |
| Q35904838 | Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India |
| Q79861758 | C-reactive protein in HIV-infected patients--could it be a marker of immunosuppression? |
| Q58091194 | Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells |
| Q36889651 | Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study |
| Q40200660 | Cost-effective HIV-1 virological monitoring in resource-limited settings using a modified commercially available qPCR RNA assay |
| Q36634803 | Darunavir is a good third-line antiretroviral agent for HIV type 1-infected patients failing second-line protease inhibitor-based regimens in South India |
| Q36192090 | Design of the Indian NCA study (Indian national collaboration on AIDS): a cluster randomized trial to evaluate the effectiveness of integrated care centers to improve HIV outcomes among men who have sex with men and persons who inject drugs in India |
| Q35692199 | Differences in Evolution of HIV-1 Subtype C Reverse Transcriptase Between Children and Adults Likely Explained by Maturity of Cytotoxic T-Lymphocyte Responses |
| Q40448451 | Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India. |
| Q36586423 | Diverse Rates of Depression Among Men Who Have Sex with Men (MSM) Across India: Insights from a Multi-site Mixed Method Study. |
| Q35578347 | Domestic violence and forced sex among the urban poor in South India: implications for HIV prevention |
| Q45090499 | Epidemiological studies on pulmonary pathogens in HIV-positive and -negative subjects with or without community-acquired pneumonia with special emphasis on Mycoplasma pneumoniae. |
| Q35008591 | Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India |
| Q35569047 | Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India |
| Q37177762 | GB virus infection: a silent anti-HIV panacea within? |
| Q36252631 | Gender Differences in Factors Related to HIV Risk Behaviors among People Who Inject Drugs in North-East India |
| Q36276201 | HIV care continuum among men who have sex with men and persons who inject drugs in India: barriers to successful engagement |
| Q46817716 | HIV, HBV and HCV prevalence among high risk populations in South India |
| Q44760760 | HIV-1 drug resistance among newly HIV-1 infected individuals attending tertiary referral center in Chennai, India |
| Q37388226 | HIV-1 reverse transcriptase nucleotide substitutions in subtype C-infected, drug-naive, and treatment-experienced patients in South India |
| Q44752153 | HIV-I reverse transcriptase variation in plasma and genital secretion of antiretroviral-naive females |
| Q35137055 | High HIV burden among people who inject drugs in 15 Indian cities |
| Q35633507 | High HIV prevalence and incidence among MSM across 12 cities in India |
| Q37349751 | High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern |
| Q33967322 | High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region. |
| Q38428765 | Impact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India |
| Q37311978 | Incidence of atazanavir- associated adverse drug reactions in second -line drugs treated south Indian HIV-1 infected patients |
| Q92883854 | Integrated HIV testing, prevention, and treatment intervention for key populations in India: a cluster-randomised trial |
| Q90657051 | Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial |
| Q35770858 | Low-cost assays for monitoring HIV infected individuals in resource-limited settings |
| Q58130226 | Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients |
| Q40288113 | Occurrence of enteric parasitic infections among HIV-infected individuals and its relation to CD4 T-cell counts with a special emphasis on coccidian parasites at a tertiary care centre in South India |
| Q40043917 | Performance of point-of-care Xpert HIV-1 plasma viral load assay at a tertiary HIV care centre in Southern India |
| Q40119151 | Performance of urinalysis tests in screening for significant bacteriuria among human immunodeficiency virus-infected subjects in South India |
| Q43282850 | Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, Southern India |
| Q35676056 | Reverse transcriptase substitution at codons 208 and 228 among treatment-experienced HIV-1 subtype-C-infected Indian patients is strongly associated with thymidine analogue mutations |
| Q40133324 | Risk factors and frequency of tuberculosis-associated immune reconstitution inflammatory syndrome among HIV/Tuberculosis co-infected patients in Southern India |
| Q104745338 | SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers |
| Q37305630 | Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India |
| Q37550353 | Short Communication: Analysis of Selection Pressure and Mutational Pattern of HIV Type 1 Reverse Transcriptase Region Among Treated and Nontreated Patients |
| Q36433533 | Short Communication: Nucleotide Variation and Positively Selected Sites in HIV Type 1 Reverse Transcriptase Among Heterosexual Transmission Pairs |
| Q41391847 | TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens |
| Q35858397 | The Hidden Burden of Dengue and Chikungunya in Chennai, India |
| Q35157869 | The association between HIV-1 subtype C antiretroviral resistance and HLA prevalence in southern India |
| Q36154288 | The efficacy of sirolimus- and paclitaxel-eluting stents: a meta-analysis of randomized controlled trials. |
| Q36960817 | The emerging HIV epidemic among men who have sex with men in Tamil Nadu, India: geographic diffusion and bisexual concurrency |
| Q33935693 | The impact of HIV and high-risk behaviours on the wives of married men who have sex with men and injection drug users: implications for HIV prevention |
| Q47839428 | The impact of a private-public partnership delivery system on the HIV continuum of care in a South Indian city |
| Q33793640 | The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India |
| Q36103428 | The prevalence and impact of childhood sexual abuse on HIV-risk behaviors among men who have sex with men (MSM) in India |
| Q45395317 | The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India |
| Q34075539 | The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions |
| Q35203268 | The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India |
| Q36419515 | Unusual insertion and deletion at codon 67 and 69 of HIV type 1 subtype C reverse transcriptase among first-line highly active antiretroviral treatment-failing South Indian patients: association with other resistance mutations |
| Q50857636 | Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings. |
| Q36607906 | Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India |
| Q35102720 | Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India |
Search more.